The way we partner

Passionate partnerships are a central way of doing business at Pharmacosmos. They are also central to our aspiration to change the way iron deficiency is prevented and treated in humans and animals. Through partnerships we form ideas, develop compounds, run non-clinical and clinical trials, secure distribution chains and increase our global sales and marketing presence.

Partnering to us means co-creation, taking strides together and making sure that success is to our mutual benefit. We focus on being dependable, transparent and trustworthy – and taking the time and allocating the resources needed to foster a valuable and respecting collaboration.

We have a great track record in establishing and developing long-term partnerships – and wish to continue doing so.

Global presence

We are committed to change the way iron deficiency anaemia is prevented and treated in humans and animals – all over the world. To do that, we work focused to expand our global presence and have done so with success since 1965.

We have our own organisation's in Denmark, the US, China, UK, Ireland, Sweden and Norway and we work through dedicated partnerships with diligent people and capable organisation's elsewhere around the globe.

We furthermore partner with the international medical community in search for even better treatments for humans and veterinary use. Over the years and continuing today, we have conducted and are conducting clinical studies in a number of countries, including the US. We drive our clinical studies out of Denmark and execute them with assistance from local contract research organisation's.

For more information please visit


Pharmacosmos works closely and actively with our partners around the world for the marketing of our IV iron products. We believe that the combination of our partners' local expertise within Sales, Marketing and Market Access combined with Pharmacosmos' deep knowledge of the international market for IV iron and the treatment of Iron Deficiency, is the foundation for a successful business and a solid long-term business relationship. Key words in the relationships with our partners are dedication, professionalism, long term relationships and mutual respect and understanding.

Apart from our partners being professional and competent within the marketing of ethical pharmaceutical products, we ask our partners to be dedicated to making Monofer a success in a close cooperation with Pharmacosmos, which entails that sufficient dedicated resources are assigned to the Monofer business. Furthermore, the partner shoul have existing business in some of the relevant segments, typically gastroenterology, nephrology, gyn/obs, surgery and cardiovascular.


Pharmacosmos is constantly looking for skilled partners for Monofer® in markets where we are not yet present

A future business partner for a market can obtain the exclusive license for a number of years for marketing of Monofer, and a potential partner must master:

  • Understanding and handling of complex IV Pharmaceuticals
  • Medically oriented, used to use publications of clinical trials in training
  • Marketing and training in relevant hospital specialties
  • Skilled within collaboration with KOL’s and doctors
  • A full organization covering Medical, MSL’s, training, marketing, sales reps, Pharmacovigilance etc.
  • Willing to build up the branded business over a longer period of time to exploit the full potential and to open new segments of the market.
  • Healthy financials

If you are interested in becoming one of our successful business partners, please submit basic info to us as per below list:

  • Size of the IV Iron market in the market (volume and value and the growth rate)
  • Which other products within IV Iron exist in the market today
  • Which Therapeutic Areas (Specialist groups) do you visit today
  • Which other brands do you currently have in your portfolio
  • The size of your company (Turnover and employees)
  • Company presentation (Web-page)

Send us an e-mail at


We are looking to in-license complementary specialty care products within gastroenterology, nephrology, gyn/obs, surgery and cardiovascular diseases. We are seeking pan-EU rights or alternatively rights to the Nordic countries, Germany, Ireland, and/or the UK.  

Our focus is on complex and innovative products with IP protection and a scientific content in either late development, in filing phase, or already approved.


We collaborate with leading medical experts in driving research to uncover new clinical insights of iron metabolism and iron deficiency that have the potential to change the way iron deficiency is prevented and treated in humans.

We are actively seeking opportunities to collaborate on investigator sponsored studies.